Research

March 7, 2023

Treating delirium detected in the ED

Higher intensity physical or occupational therapy may be a useful intervention to shorten delirium duration in older hospitalized adults, Vanderbilt researchers recently reported.

By Leigh MacMillan
March 6, 2023

Cell-free hemoglobin in pulmonary hypertension

Cell-free hemoglobin generated by the lungs may be a therapeutic target for treating pulmonary arterial hypertension, Vanderbilt researchers found.

By Leigh MacMillan
March 2, 2023

Sex counts in the brain as seasons change

Photoperiod, or length of day, has sex-specific impacts on dopamine dynamics in the brain, offering insights into sex differences in neuropsychiatric disorders, Vanderbilt researchers report.

By Paul Govern
March 2, 2023

Sex-specific regulation of kidney signals

Links between estrogen signaling and sodium excretion by the kidney could help explain a reduced risk of hypertension in females versus males.

By Kelsey Pinckard
February 28, 2023

Discovery lecture features electron microscopy leader Cheng

Yifan Cheng, PhD, a leader in electron microscopy technology development and structural studies of biological macromolecules, will deliver the next Discovery Lecture on Thursday, March 9.

By Leigh MacMillan
Julie Bastarache, MD, has been appointed Assistant Vice President for Clinical & Translational Scientist Development.
February 23, 2023

Bastarache takes on new role for research career development

Julie Bastarache, MD, has been appointed Assistant Vice President for Clinical & Translational Scientist Development at Vanderbilt University Medical Center.

By Leigh MacMillan
February 21, 2023

Diabetes drug may improve asthma

New biomarker finding strengthens the case for using GLP-1R agonists to treat patients with Type 2 diabetes who also suffer from asthma.
By Sarah E. Glass
February 20, 2023

Probing hellbender health

Understanding how hellbenders — large, fully aquatic salamanders — fight fungal pathogens and disease is important for protecting these unique stream predators; Vanderbilt researchers add new insights.
By Leigh MacMillan
February 16, 2023

Breast cancer genetics: new insights

Largest genetic study of breast cancer to date identifies 222 genetic risk loci, 137 genes and multiple signaling pathways associated with risk, providing important new insights.
By Leigh MacMillan
February 16, 2023

Targeted therapy for neuroendocrine tumors

Cancer therapies that target VEGF receptor appear safe and effective for patients with pancreatic and non-pancreatic neuroendocrine tumors, meta-analysis of phase 2/3 clinical trials demonstrates.
By Kelsey Pinckard
February 15, 2023

Study finds chronically disrupted sleep may increase risk for heart disease

Vanderbilt research found that sleep irregularity — chronically disrupted sleep and highly variable sleep durations night after night — may increase the risk for atherosclerosis.
By Bill Snyder
February 9, 2023

Team’s imaging strategy enhances lipedema treatment

A collaborative team at Vanderbilt is transforming the diagnosis and treatment of lipedema, a debilitating, abnormal deposition of fatty tissue that afflicts an estimated 17 million women in the United States.
By Bill Snyder
February 7, 2023

A new view of a cholesterol carrier

Vanderbilt researchers developed a novel method to measure small RNAs carried by HDL and demonstrated that these molecules circulate in greater concentrations than previously believed and are likely to contribute to communication between immune cells.
By Kelsey Pinckard